GSK acquires exclusive rights from Syndivia for antibody drug conjugate in prostate cancer
GSK Acquires Exclusive Rights for Prostate Cancer Treatment GSK plc and Syndivia, a private biotechnology company, have announced an agreement granting GSK exclusive worldwide rights to de…